Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Locally Advanced SCCHN
NCT00371566Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, single-blind trial in squamous cell carcinoma of the head and neck (HNSCC) comparing Lapatinib with Placebo (2 arms). Primary endpoint: Change From Baseline of the Apoptotic Index During Treatment Phase at Week 2. Started Mar 2006; status: completed.
02
Drugs
lapatinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00371566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371566.